company background image
AMTI

Applied Molecular Transport NasdaqGS:AMTI Stock Report

Last Price

US$1.02

Market Cap

US$39.7m

7D

-1.9%

1Y

-93.8%

Updated

27 Nov, 2022

Data

Company Financials +
AMTI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

AMTI Stock Overview

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.

Applied Molecular Transport Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Applied Molecular Transport
Historical stock prices
Current Share PriceUS$1.02
52 Week HighUS$17.91
52 Week LowUS$0.80
Beta1.3
1 Month Change14.12%
3 Month Change-30.14%
1 Year Change-93.75%
3 Year Changen/a
5 Year Changen/a
Change since IPO-94.33%

Recent News & Updates

We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Nov 13
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Applied Molecular Transport GAAP EPS of -$0.93

Aug 04

Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Jul 27
Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Recent updates

We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Nov 13
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

Jul 27
Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky

We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

Apr 28
We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Jan 08
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Aug 29
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely

Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Apr 05
Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans

Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Feb 11
Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?

Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Dec 21
Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation

Shareholder Returns

AMTIUS BiotechsUS Market
7D-1.9%0.4%1.3%
1Y-93.8%-14.4%-18.5%

Return vs Industry: AMTI underperformed the US Biotechs industry which returned -14.4% over the past year.

Return vs Market: AMTI underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is AMTI's price volatile compared to industry and market?
AMTI volatility
AMTI Average Weekly Movement15.1%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: AMTI is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: AMTI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2010125Tahir Mahmoodhttps://www.appliedmt.com

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company’s lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects.

Applied Molecular Transport Inc. Fundamentals Summary

How do Applied Molecular Transport's earnings and revenue compare to its market cap?
AMTI fundamental statistics
Market CapUS$39.72m
Earnings (TTM)-US$133.93m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMTI income statement (TTM)
RevenueUS$0
Cost of RevenueUS$30.11m
Gross Profit-US$30.10m
Other ExpensesUS$103.82m
Earnings-US$133.93m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.44
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did AMTI perform over the long term?

See historical performance and comparison